INTERNATIONAL PATENT: HYPER CORPORATION INC., ㈜하이퍼코퍼레이션 FILES APPLICATION FOR "NOVEL COMPOUND AS NLRP3 INHIBITOR AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME"

GENEVA, April 29 -- HYPER CORPORATION INC. (#A-517, 186 Gasan digital 1-roGeumcheon-guSeoul 08502), ㈜하이퍼코퍼레이션 (서울특별시금천구가산디지털1로 186, #A-517) filed a patent application (PCT/KR2025/016374) for "NOVEL COMPOUND AS NLRP3 INHIBITOR AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME" on Oct 16, 2025. With publication no. WO/2026/084481, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

In...